Search

1. Asyouwere (Volume I, Number 7, March 29, 1919)

2. Asyouwere (Volume I, Number 6, March 22, 1919)

3. Asyouwere (Volume I, Number 8, April 5, 1919)

4. Asyouwere (Volume I, Number 9, April 12, 1919)

5. Asyouwere (Volume I, Number 10, April 19, 1919)

6. Asyouwere (Volume I, Number 11, April 26, 1919)

7. Asyouwere (Volume I, Number 13, May 10, 1919)

8. Asyouwere (Volume I, Number 15, May 24, 1919)

9. Asyouwere (Volume I, Number 17, June 7, 1919)

10. Asyouwere (Volume I, Number 20, June 28, 1919)

11. Asyouwere (Volume I, Number 19, June 21, 1919)

12. Asyouwere (Volume I, Number 24, Anniversary Edition, July 12, 1919)

13. The tropics: their resources, people, and future : a description of the tropical lands of Africa, Asia, Central and South America, Australasia and the Pacific; their natural products, scenery, inhabitants and industries, and the possibilities of their future development

Author(s):

Enock, C. Reginald (Charles Reginald), 1868-1970 author

Publication:

New York : Charles Scribner's Sons, 1915

Subject(s):

Geography
Tropical Climate

14. Special protocol assessment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 2018

Subject(s):

Clinical Trials as Topic -- standards
Drug Approval
Drug Evaluation, Preclinical -- standards
Research Design
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

15. Enforcement policy--OTC sunscreen drug products marketed without an approved application

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Health Policy
Marketing
Sunscreening Agents
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

16. Acne vulgaris: establishing effectiveness of drugs intended for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Acne Vulgaris -- drug therapy
Drug Evaluation -- standards
Clinical Trials as Topic -- standards
Endpoint Determination
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

17. Anthrax: developing drugs for prophylaxis of inhalational anthrax

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Anthrax -- drug therapy
Anthrax -- prevention & control
Antibiotic Prophylaxis
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Inhalation Exposure
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

18. Complicated intra-abdominal infections: developing drugs for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Anti-Bacterial Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation -- standards
Drugs, Investigational -- pharmacokinetics
Intraabdominal Infections -- drug therapy
Microbiological Techniques -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

19. M7(R1) assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, March 2018

Subject(s):

Carcinogenicity Tests -- standards
Carcinogens
Chemistry, Pharmaceutical
DNA Damage -- genetics
Drug Contamination -- prevention & control
Mutagenicity Tests -- standards
Mutagens
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

20. Bioanalytical method validation

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Drug Evaluation, Preclinical -- standards
Reproducibility of Results
Research Design -- standards
Validation Studies as Topic
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

21. Assessing user fees under the biosimilar user fee amendments of 2017

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, June 2018

Subject(s):

Biosimilar Pharmaceuticals -- economics
Fees and Charges
Investigational New Drug Application -- economics
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

22. Extension of certain tobacco product compliance deadlines related to the final deeming rule: (revised)

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Product Labeling -- standards
Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

23. Elemental impurities in drug products

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Chemistry, Pharmaceutical
Drug Contamination
Quality Control
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

24. Dissolution testing and acceptance criteria for immediate-release solid oral dosage form drug products containing high solubility drug substances

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, August 2018

Subject(s):

Chemistry, Pharmaceutical
Drug Liberation
Solubility
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

25. Japanese medical equipment (Number 168, January 24, 1946)

26. Japanese medical equipment (Number 171, January 31, 1946)

27. Figura matricis

Publication:

Bethesda, MD : U.S. National Library of Medicine, National Institutes of Health, Health & Human Services, [2018]

Subject(s):

Uterus

28. Threshold

Publication:

[New York, N.Y.] : Audio Productions, [1969]

Subject(s):

Anesthesiology
Biomedical Research
Pain Threshold
Pain Management

29. Insurance markets: health benefit costs : employers share the pain

Publication:

[Oakland, Calif.] : California HealthCare Foundation, [2003]

Subject(s):

Cost Sharing -- economics
Employer Health Costs
California

30. Impact of the 2004-05 May revision on health programs in California

Publication:

Oakland, Calif. : California HealthCare Foundation, c2004

Subject(s):

Health Expenditures
Managed Care Programs -- economics
Medicaid -- economics
California

31. Improving decision support tools for the long term care consumer

Publication:

Oakland, Calif. : California HealthCare Foundation, [2008]

Subject(s):

Community Participation
Databases, Factual
Decision Support Techniques
Long-Term Care
Patient Participation
California

32. Independent medical review experiences in California. Phase I, Cases of investigational/experimental treatments

Publication:

Oakland, Calif. : California HealthCare Foundation, c2002

Subject(s):

Health Maintenance Organizations -- legislation & jurisprudence
Insurance, Health -- legislation & jurisprudence
Patient Advocacy
California

33. How policy changes impact enrollment: a look at three county efforts

Author(s):

Chimento, Lisa.

Publication:

Oakland, Calif. : California HealthCare Foundation, c2004

Subject(s):

Insurance, Health -- legislation & jurisprudence
Insurance Coverage -- organization & administration
Health Policy
Medically Uninsured
Local Government
California

34. Implementing the Federal Health Privacy Rule in California: a guide for pharmacists, physical therapists, and others

Author(s):

Pritts, Joy.

Publication:

[Oakland, Calif.] : California HealthCare Foundation, c2002

Subject(s):

Confidentiality -- legislation & jurisprudence
Forms and Records Control -- legislation & jurisprudence
Medical Records -- legislation & jurisprudence
California
United States.

35. Improving access to health care in California: testing new roles for providers

Author(s):

Dower, Catherine

Publication:

Oakland, Calif. : California HealthCare Foundation, [2009]

Subject(s):

Allied Health Personnel
Health Services Accessibility
Health Workforce
Role
California

36. The impact of federal stimulus funds on community health centers in California

Publication:

[Oakland, Calif.] : California HealthCare Foundation, [2009]

Subject(s):

Community Health Centers -- economics
Community Health Centers -- legislation & jurisprudence
Community Networks -- economics
Community Networks -- legislation & jurisprudence
Financing, Government -- economics
Financing, Government -- legislation & jurisprudence
California
United States

37. Is there a doctor in the house?: physician liability fears and quality of care in nursing homes

Author(s):

Kapp, Marshall B.

Publication:

Oakland, Calif. : California HealthCare Foundation, [2008]

Subject(s):

Attitude of Health Personnel
Defensive Medicine
Fear
Liability, Legal
Nursing Homes
Physicians -- psychology
California
United States

38. Facility definition under Section 503B of the Federal Food, Drug, and Cosmetic Act

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, May 2018

Subject(s):

Drug Compounding -- standards
Drug Industry -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.

39. Considerations for design, development, and analytical validation of next generation sequencing (NGS)--based in vitro diagnostics (IVDs) intended to aid in the diagnosis of suspected germline diseases: guidance for stakeholders and Food and Drug Administration staff

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 13, 2018

Subject(s):

Genetic Testing
Germ-Line Mutation
Diagnostic Test Approval
Reagent Kits, Diagnostic -- standards
Sequence Analysis, DNA
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

40. Clinical trial imaging endpoint process standards

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, April 2018

Subject(s):

Clinical Trials as Topic -- standards
Diagnostic Imaging -- standards
Endpoint Determination -- standards
Research Design -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

41. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components

Publication:

Silver Spring, MD : Center for Biologics Evaluation and Research, July 2018

Subject(s):

Blood Component Transfusion
Blood Safety -- standards
Blood Transfusion
Zika Virus Infection -- blood
Zika Virus Infection -- transmission
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

42. Labeling for biosimilar products

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, July 2018

Subject(s):

Biosimilar Pharmaceuticals
Drug Labeling -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

43. Nonallergic rhinitis: developing drug products for treatment

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, September 2018

Subject(s):

Clinical Trials as Topic
Drug Evaluation
Rhinitis -- drug therapy
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

44. Japanese medical equipment (Number 152, December 27, 1945)

45. Japanese medical equipment (Number 170, January 29, 1946)

46. Creating better systems of care for adults with disabilities: lessons for policy and practice

Author(s):

Hostetter, Martha, author
Klein, Sarah, author

Publication:

[New York, N.Y.] : Commonwealth Fund, September 2018

Subject(s):

Persons with Disabilities -- rehabilitation
Health Services Accessibility
Health Services for Persons with Disabilities
Health Services Needs and Demand
Intellectual Disability -- rehabilitation
Intellectual Disability -- therapy
Mental Disorders -- rehabilitation
Mental Disorders -- therapy
Social Support
Florida
Minnesota
New York City
Pennsylvania
Tennessee
United States

47. Japanese medical equipment (Number 172, February 8, 1946)

48. Japanese medical equipment (Number 174, February 12, 1946)

49. Implementing the Federal Health Privacy Rule in California: a guide for health care providers

Author(s):

Pritts, Joy.

Publication:

[Oakland, Calif.] : California Healthcare Foundation, c2002

Subject(s):

Confidentiality -- legislation & jurisprudence
Forms and Records Control -- legislation & jurisprudence
Medical Records -- legislation & jurisprudence
California

50. Registration and product listing for owners and operators of domestic tobacco product establishments: (revised)

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2017

Subject(s):

Registries -- standards
Tobacco Products -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
United States.